Capricor Therapeutics
CAPR
#4976
Rank
โ‚ฌ1.44 B
Marketcap
25,05ย โ‚ฌ
Share price
-3.51%
Change (1 day)
135.81%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -โ‚ฌ72.31 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ11.13 Million. In 2024 the company made an earning of -โ‚ฌ35.09 Million a decrease over its 2023 earnings that were of -โ‚ฌ19.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ72.31 Million106.1%
2024 -โ‚ฌ35.09 Million81.57%
2023 -โ‚ฌ19.33 Million-23.2%
2022 -โ‚ฌ25.16 Million44.93%
2021 -โ‚ฌ17.36 Million46.61%
2020 -โ‚ฌ11.84 Million78.71%
2019 -โ‚ฌ6.63 Million-49.7%
2018 -โ‚ฌ13.17 Million-724.78%
2017 โ‚ฌ2.1 M-112.93%
2016 -โ‚ฌ16.31 Million46.27%
2015 -โ‚ฌ11.15 Million106.82%
2014 -โ‚ฌ5.39 Million-48.41%
2013 -โ‚ฌ10.45 Million977.23%
2012 -โ‚ฌ0.97 Million-77.11%
2011 -โ‚ฌ4.24 Million-22.35%
2010 -โ‚ฌ5.46 Million-20.17%
2009 -โ‚ฌ6.84 Million-41.17%
2008 -โ‚ฌ11.62 Million41.05%
2007 -โ‚ฌ8.24 Million1098.87%
2006 -โ‚ฌ0.69 Million4101.55%
2005 -โ‚ฌ0.02 Million-0.97%
2004 -โ‚ฌ0.02 Million17.87%
2003 -โ‚ฌ0.02 Million3.66%
2002 -โ‚ฌ0.02 Million-30.11%
2001 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ29.08 B-41,022.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.55 B-876.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.69 Billion 857.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.25 Billion 250.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ4.16 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.23 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA